MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
7.04
+0.14
+2.03%
Opening 10:32 05/12 EDT
OPEN
7.03
PREV CLOSE
6.90
HIGH
7.12
LOW
7.01
VOLUME
5.75K
TURNOVER
--
52 WEEK HIGH
34.27
52 WEEK LOW
3.920
MARKET CAP
59.78M
P/E (TTM)
-0.1930
1D
5D
1M
3M
1Y
5Y
1D
Scilex Announces Special Dream Bowl Token Dividend
TipRanks · 23h ago
Scilex to distribute 5 Dream Bowl Meme Coin I tokens per share dividend May 26
PUBT · 1d ago
Weekly Report: what happened at SCLX last week (0504-0508)?
Weekly Report · 1d ago
Scilex Subsidiary Reshapes Phoenix Asia via $1B Share Deal
TipRanks · 05/05 17:49
Scilex’s ACEA Thera, ACEA Pharma enter definitive agreement with Phoenix Asia
TipRanks · 05/05 17:11
Scilex unit ACEA Therapeutics agrees to sell ACEA Pharma to Phoenix Asia for $1 billion
PUBT · 05/05 17:04
Scilex Subsidiary ACEA Therapeutics To Merge ACEA Pharma Into Phoenix Asia In $1B Share Exchange Deal
Benzinga · 05/05 17:02
SCILEX HOLDING CO - ACEA THERA TO OWN ABOUT 82% OF GO-FORWARD COMPANY UPON CLOSING
Reuters · 05/05 17:00
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.